// App-Quantinova.ai

2268 : Higher Doses of Prophylactic Anticoagulation Is More Effective in Preventing Venous Thromboembolism in Morbidly Obese Inpatients.

Researchers

Presenter

  • Paul Milligan

Principal Investigators

  • Catherine A Wong

  • Mark S Thoelke

  • Eli N Deal

  • Brian F Gage

Medical Centers

  • Department of Internal Medicine, Barnes-Jewish Hospital, Saint Louis, MO, USA,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Obesity

Biomarkers

  • Body mass index

Drug/Treatment

  • Heparin

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved